News from csa medical A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Oct 03, 2019, 08:50 ET CSA Medical Presents Positive Feasibility Study Results for its RejuvenAir® System at the 2019 European Respiratory Society International Congress in Madrid

CSA Medical, Inc., presented positive 12-month results of its feasibility study for the RejuvenAir Metered Cryospray™ system yesterday at the 2019...


May 20, 2019, 13:15 ET CSA Medical Announces Data Presented at Digestive Disease Week 2019 Supporting truFreeze Spray Cryotherapy for the Treatment of Barrett's Esophagus

CSA Medical today announced the presentation of three clinical abstracts highlighting truFreeze® Spray Cryotherapy for treatment of Barrett's...


May 20, 2019, 11:30 ET CSA Medical Announces New Data at Digestive Disease Week 2019 Supporting the Safety and Efficacy of truFreeze Spray Cryotherapy for Palliation of Esophageal Cancer

CSA Medical today announced the presentation of two clinical abstracts highlighting the safety and efficacy of truFreeze® Spray Cryotherapy for...


May 09, 2019, 16:00 ET CSA Medical's truFreeze® Spray Cryotherapy to be Featured During Digestive Disease Week® 2019

CSA Medical today announced that the company's truFreeze® Spray Cryotherapy will be featured in five sessions at Digestive Disease Week® (DDW®) 2019. ...


Dec 14, 2018, 08:00 ET CSA Medical's truFreeze® Spray Cryotherapy Highlighted at New York Society for Gastrointestinal Endoscopy Annual Meeting 2018

CSA Medical announced the first live case highlighting the use of the company's truFreeze® Spray Cryotherapy in a patient with esophageal cancer that ...


Sep 18, 2018, 16:00 ET RejuvenAir® Metered Cryospray™ Shows Promise as Treatment for COPD Patients with Chronic Bronchitis

CSA Medical Inc. presented positive results of its feasibility study of the RejuvenAir® Metered Cryospray™ system at the 2018 European Respiratory...


May 31, 2018, 10:52 ET CSA Medical To Highlight RapidAV Catheter and Presentations of truFreeze Clinical Studies at DDW 2018

CSA Medical, Inc. is pleased to announce the presentation of key findings related to truFreeze® Spray Cryotherapy at this year's Digestive Disease...


Apr 02, 2018, 12:32 ET CSA Medical Supports Esophageal Cancer Awareness Month

April is Esophageal Cancer Awareness month. CSA Medical is committed to raising awareness of Esophageal Cancer and the importance of early diagnosis...


Mar 01, 2018, 01:12 ET CSA Medical Announces the Completion of Treatments in the RejuvenAir Safety and Feasibility Study for patients with Chronic Bronchitis

CSA Medical, Inc. announced the completion of the treatment phase for its ongoing study The Safety and Feasibility Study of RejuvenAir for Treating...


Feb 06, 2018, 08:00 ET New Study Finds truFreeze® Spray Cryotherapy Less Painful than Radiofrequency Ablation for Treatment of Barrett's Esophagus Related Diseases

CSA Medical is pleased to announce that in a multi-center prospective study conducted at three leading academic centers published in the Journal of...


Jun 19, 2017, 12:43 ET CSA Medical Appoints Jean Bjerke, Vice President of Marketing

CSA Medical, Inc, has appointed Jean Bjerke, MBA as Vice President of Marketing. In this role, Ms. Bjerke will have the responsibility of developing...


May 30, 2017, 18:01 ET CSA Medical Announces Expansion of truFreeze Label to Include Barrett's Esophagus with High Grade Dysplasia

CSA Medical announced on Thursday, the expansion of its truFreeze® label to refer specifically to Barrett's Esophagus with high grade dysplasia. This ...


May 09, 2017, 06:01 ET CSA Medical Announces Presentations of truFreeze® Clinical Studies at Digestive Disease Week

CSA Medical today announced new clinical data related to its truFreeze® Spray Cryotherapy (SCT) system to be presented in a series of oral and poster ...


Apr 11, 2017, 16:22 ET CSA Medical announces first publication of the RejuvenAir Metered Cryospray System in the American Journal of Respiratory and Critical Care Medicine

CSA Medical, Inc., a company focused on developing spray cryotherapy devices that selectively freeze and ablate unwanted tissue inside the body,...


Dec 01, 2016, 07:44 ET CSA Medical Announces First Use of Significantly Reduced Diameter Cryogen Decompression Tube in a truFreeze® Spray Cryotherapy Case

CSA Medical today announced the initial use of a modified cryogen decompression tube (CDT) during a truFreeze Spray Cryotherapy (SCT) case at...


Nov 16, 2016, 06:11 ET CSA Medical Commences Phase B of the RejuvenAir System Safety and Feasibility Study For the Treatment of Chronic Bronchitis Patients

CSA Medical, Inc., a company focused on developing spray cryotherapy devices that selectively freeze and ablate unwanted tissue inside the body,...


Sep 07, 2016, 10:05 ET CSA Medical Presented Early Clinical Data on the RejuvenAir Metered Cryospray System at the European Respiratory Society (ERS) Conference

CSA Medical held a mini-symposium at the ERS Conference on Tuesday, September 6, 2016 in London, England. The symposium highlighted early data from...


Aug 10, 2016, 07:01 ET CSA Medical will Host a Symposium featuring the RejuvenAir Metered Cryospray System at the European Respiratory Society (ERS) Conference

CSA Medical announces its upcoming mini-symposium at the ERS Conference, taking place on Tuesday, September 6, 2016 in London, England. The symposium ...


May 10, 2016, 08:45 ET CSA Medical Announces New Thermal Penetration Results for Multiple Cryogenic Sprays at DDW

CSA Medical announced novel thermal penetration modeling and data related to its truFreeze® liquid nitrogen spray cryotherapy system in addition to...


May 03, 2016, 09:01 ET CSA Medical Announces the Presentation of the truFreeze® System Pulmonary Studies at WCBIP and ATS

Researchers from leading academic healthcare institutions and CSA Medical, Inc. announce the acceptance of abstracts at the World Congress of...


Apr 12, 2016, 11:41 ET CSA Medical Announces the First Chronic Bronchitis Patient Treatments in the RejuvenAir® System Safety and Feasibility Study

CSA Medical, Inc., a company focused on developing spray cryotherapy devices that selectively freeze and ablate unwanted tissue inside the body,...


Apr 07, 2016, 07:06 ET CSA Medical Announces Presentations of truFreeze® Clinical Studies at DDW

CSA Medical today announced new clinical data related to its truFreeze® spray cryotherapy system to be presented in a series of oral and poster...


Mar 21, 2016, 06:01 ET CSA Medical Announces the First Presentation of the RejuvenAir® System Metered Cryospray™ Clinical Data

Researchers from leading academic healthcare institutions and CSA Medical, Inc. announce the acceptance of abstracts at the World Congress of...